re: amp+share analysis Looking attractive following recent price decline
We review the investment case for AMP following its recent share price decline and changes in equity market sentiment. AMP shares have fallen close to 20% from their recent peak of $8.00 and are now trading below our reduced valuation and price target. With the stock offering a forecast 12-month return of 21.8% (17.3% capital and 4.5% dividend yield) we have upgraded our recommendation to BUY.
Sourse:share analysis(10/5/05)
- Forums
- ASX - By Stock
- AMP
- what a dog
what a dog, page-77
Featured News
Add AMP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.015(1.00%) |
Mkt cap ! $3.848B |
Open | High | Low | Value | Volume |
$1.50 | $1.52 | $1.49 | $8.267M | 5.465M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 84004 | $1.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.53 | 37586 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 69435 | 1.510 |
1 | 700 | 1.495 |
2 | 10000 | 1.490 |
1 | 19500 | 1.485 |
6 | 44027 | 1.480 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 1000 | 1 |
1.535 | 28000 | 2 |
1.540 | 20250 | 2 |
1.545 | 1002 | 1 |
1.550 | 159516 | 13 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AMP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online